
Areas of Expertise
Conditions I Treat
- Peripheral T-cell lymphomas
- Cutaneous lymphoma
- Hodgkin lymphoma (Hodgkin’s disease)
My Specialties
- Clinical trials
Get to Know Me
I am a hematologist-oncologist specializing in the care of people with lymphoma. This includes:
- T-cell lymphomas
- Cutaneous lymphomas, including mycosis fungoides and Sézary syndrome
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
I am honored to be a core member of the Lymphoma Service at Memorial Sloan Kettering Cancer Center (MSK), where I am dedicated to providing world-class, personalized, and humanistic care to patients facing a lymphoma diagnosis.
Read more
My main goal when meeting new patients is to establish a partnership. A diagnosis of lymphoma can be frightening. I make it my priority to learn the individual goals of my patients and their families, explain the diagnosis and treatment options, and listen to and answer questions. It is important to me that my patients feel comfortable as we embark on their care journey together.
I value teamwork not only with my patients, but also with my MSK colleagues. At MSK, I am fortunate to work on a multidisciplinary team with other lymphoma specialists, advanced practice providers, nurses, and social workers. We are all dedicated to providing comprehensive care (care for the whole patient, not just their medical needs).
The treatment of lymphoma is continually advancing, and I am proud to be at the forefront of defining new treatments for lymphoma. I design and lead clinical trials of new drugs and strategies for the treatment of lymphoma, in particular Hodgkin lymphoma and certain rare lymphomas, such as T-cell lymphomas and cutaneous lymphomas. I work within an active, renowned team of expert cancer doctors and scientists to lead clinical trials designed to make treatments better, improve quality of life, and change the lives of people with lymphoma for the better.
Outside of work, I enjoy quality time with my family, bike riding in Central Park, and vacationing in Maine.
A lymphoma specialist is a doctor with special training in diagnosing and treating lymphoma.
- Assistant Attending Physician
Conditions I Treat
- Peripheral T-cell lymphomas
- Cutaneous lymphoma
- Hodgkin lymphoma (Hodgkin’s disease)
- Non-Hodgkin lymphoma (NHL)
- Mycosis fungoides (MF)
- Lymphoma
My Specialties
- Clinical trials
Education
- MD, State University of New York (SUNY) Upstate Medical University
Residencies
- Internal Medicine, Beth Israel Deaconess Medical Center
Fellowships
- Medical Oncology/Hematology, Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
Awards and Honors
- Chief Hematology Fellow, Memorial Sloan Kettering Cancer Center (2022-2023)
- Mortimer J. Lacher Lymphoma Fellow (2021-2023)
- Abstract Achievement Award, American Society of Hematology (2022)
- Gold Humanism Honor Society (2019)
- Alpha Omega Alpha Honor Medical Society (2018)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

Contact and Location
Dr. Stuver sees patients at two locations.






Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Stuver
- A Phase 1/2 Study of STP938 in People With B-Cell or T-Cell Lymphoma
- A Phase 2 Study of Brentuximab Vedotin With Chemotherapy in People With T-Cell Lymphoma
- A Phase 2 Study of BV-AVD in People With Newly Diagnosed Bulky Hodgkin Lymphoma
- Clinical Trials Co-Investigated by Dr. Stuver
- A Phase 3 Study of Brentuximab Vedotin in People With Hodgkin Lymphoma
Read more

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Stuver’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
4.9 229 reviews
- 4.9 Provider's Explanations Easy to Understand
- 4.9 Trusts Provider with Care
- 4.9 Provider Listened Carefully
- 4.9 Likelihood of Recommending Provider
I had a superb experience with Dr. Stover. I felt respected. I thought the quality of conversation was very high. He gave me a lot of information. He gave me a lot of reassurance. He had a lovely manner, as did Sandy, his nurse practitioner and Ariel, the nurse. I don't live in New York. If I did, I would be his patient every day in a heartbeat. And even though I don't live in New York, he is going to stay in touch. I feel very good about him, and by extension, very, very good about MSK. I thank him for a wonderful experience.
Great experience. My doctor explained my condition well by drawing pictures and the treatment options with no push while other doctors in a different hospital make patients feel as if there is no other options. He was genuinely care about patients. Thanks!
Everyone was very nice, upbeat and positive. I feel that Dr Stuver has an excellent bedside manner and is personable, understanding and was definitely looking out for what works best for me and what will get the job done. Thank you.
Dr Stuver and his staff are wxcellent!!
Dr. Stuver was kind, compassionate and competent. He related to my elderly father and was respectful.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Robert Stuver discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.